Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Glioblastoma
Chemoresistance, especially temozolomide (TMZ) resistance, is a major clinical challenge in the treatment of glioblastoma (GBM). Exploring the mechanisms of TMZ resistance could help us identify effective therapies. Adenosine deaminases acting on RNA (ADARs) are very important in RNA modification th...
Saved in:
Main Authors: | Can Lu (Author), Xi Chen (Author), Yuanliang Yan (Author), Xinxin Ren (Author), Xiang Wang (Author), Bi Peng (Author), Yuan Cai (Author), Qiuju Liang (Author), Zhijie Xu (Author), Jinwu Peng (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alantolactone: A Natural Plant Extract as a Potential Therapeutic Agent for Cancer
by: Yuan Cai, et al.
Published: (2021) -
SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3β/β-Catenin Signaling Axis
by: Shuang Dai, et al.
Published: (2018) -
Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis
by: Shuang Dai, et al.
Published: (2019) -
MEOX2 promotes glioma growth and temozolomide chemoresistance
by: Tengfei Li, et al.
Published: (2024) -
The antibiotic drug tigecycline: A focus on its promising anticancer properties
by: Zhijie Xu, et al.
Published: (2016)